Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Carriage of antibiotic-resistant Gram-negative bacteria after discontinuation of selective decontamination of the digestive tract (SDD) or selective oropharyngeal decontamination (SOD).

de Jonge E, de Wilde RBP, Juffermans NP, Oostdijk EAN, Bernards AT, van Essen EHR, Kuijper EJ, Visser CE, Kesecioglu J, Bonten MJM.

Crit Care. 2018 Sep 29;22(1):243. doi: 10.1186/s13054-018-2170-2.

2.

Pain distress: the negative emotion associated with procedures in ICU patients.

Puntillo KA, Max A, Timsit JF, Ruckly S, Chanques G, Robleda G, Roche-Campo F, Mancebo J, Divatia JV, Soares M, Ionescu DC, Grintescu IM, Maggiore SM, Rusinova K, Owczuk R, Egerod I, Papathanassoglou EDE, Kyranou M, Joynt GM, Burghi G, Freebairn RC, Ho KM, Kaarlola A, Gerritsen RT, Kesecioglu J, Sulaj MMS, Norrenberg M, Benoit DD, Seha MSG, Hennein A, Pereira FJ, Benbenishty JS, Abroug F, Aquilina A, Monte JRC, An Y, Azoulay E.

Intensive Care Med. 2018 Sep;44(9):1493-1501. doi: 10.1007/s00134-018-5344-0. Epub 2018 Aug 21.

PMID:
30128592
3.

Surviving sepsis campaign: research priorities for sepsis and septic shock.

Coopersmith CM, De Backer D, Deutschman CS, Ferrer R, Lat I, Machado FR, Martin GS, Martin-Loeches I, Nunnally ME, Antonelli M, Evans LE, Hellman J, Jog S, Kesecioglu J, Levy MM, Rhodes A.

Intensive Care Med. 2018 Sep;44(9):1400-1426. doi: 10.1007/s00134-018-5175-z. Epub 2018 Jul 3.

PMID:
29971592
4.

Surviving Sepsis Campaign: Research Priorities for Sepsis and Septic Shock.

Coopersmith CM, De Backer D, Deutschman CS, Ferrer R, Lat I, Machado FR, Martin GS, Martin-Loeches I, Nunnally ME, Antonelli M, Evans LE, Hellman J, Jog S, Kesecioglu J, Levy MM, Rhodes A.

Crit Care Med. 2018 Aug;46(8):1334-1356. doi: 10.1097/CCM.0000000000003225.

PMID:
29957716
5.

Intensive Care Medicine: Organization, Education and Politics.

Kesecioğlu J.

Turk J Anaesthesiol Reanim. 2017 Dec;45(6):325-326. doi: 10.5152/TJAR.2017.241101. Epub 2017 Dec 1. No abstract available.

6.

Intranasal Stem Cell Treatment as a Novel Therapy for Subarachnoid Hemorrhage.

Nijboer CH, Kooijman E, van Velthoven CT, van Tilborg E, Tiebosch IA, Eijkelkamp N, Dijkhuizen RM, Kesecioglu J, Heijnen CJ.

Stem Cells Dev. 2018 Mar 1;27(5):313-325. doi: 10.1089/scd.2017.0148. Epub 2018 Jan 8.

PMID:
29310519
7.

Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance.

De Waele JJ, Akova M, Antonelli M, Canton R, Carlet J, De Backer D, Dimopoulos G, Garnacho-Montero J, Kesecioglu J, Lipman J, Mer M, Paiva JA, Poljak M, Roberts JA, Rodriguez Bano J, Timsit JF, Zahar JR, Bassetti M.

Intensive Care Med. 2018 Feb;44(2):189-196. doi: 10.1007/s00134-017-5036-1. Epub 2017 Dec 29.

PMID:
29288367
8.

Association of Whole Blood Tacrolimus Concentrations with Kidney Injury in Heart Transplantation Patients.

Sikma MA, Hunault CC, Kirkels JH, Verhaar MC, Kesecioglu J, de Lange DW.

Eur J Drug Metab Pharmacokinet. 2018 Jun;43(3):311-320. doi: 10.1007/s13318-017-0453-7.

9.

Intensive Care Medicine: Enterprise and Journey.

Kesecioğlu J.

Turk J Anaesthesiol Reanim. 2017 Oct;45(5):245-246. doi: 10.5152/TJAR.2017.200901. Epub 2017 Oct 1. No abstract available.

10.

Myeloperoxidase can differentiate between sepsis and non-infectious SIRS and predicts mortality in intensive care patients with SIRS.

Schrijver IT, Kemperman H, Roest M, Kesecioglu J, de Lange DW.

Intensive Care Med Exp. 2017 Sep 15;5(1):43. doi: 10.1186/s40635-017-0157-y.

11.

Soluble P-selectin as a Biomarker for Infection and Survival in Patients With a Systemic Inflammatory Response Syndrome on the Intensive Care Unit.

Schrijver IT, Kemperman H, Roest M, Kesecioglu J, de Lange DW.

Biomark Insights. 2017 Feb 7;12:1177271916684823. doi: 10.1177/1177271916684823. eCollection 2017.

12.

Notice of Retraction and Replacement: Oostdijk et al. Effects of Decontamination of the Oropharynx and Intestinal Tract on Antibiotic Resistance in ICUs: A Randomized Clinical Trial. JAMA. 2014;312(14):1429-1437.

Oostdijk EAN, Kesecioglu J, Schultz MJ, Visser CE, de Jonge E, van Essen EHR, Bernards AT, Purmer I, Brimicombe R, Bergmans D, van Tiel F, Bosch FH, Mascini E, van Griethuysen A, Bindels A, Jansz A, van Steveninck FAL, van der Zwet WC, Fijen JW, Thijsen S, de Jong R, Oudbier J, Raben A, van der Vorm E, Koeman M, Rothbarth P, Rijkeboer A, Gruteke P, Hart H, Peerbooms P, Winsser LJ, van Elsacker-Niele AW, Demmendaal K, Brandenburg A, de Smet AMGA, Bonten MJM.

JAMA. 2017 Apr 18;317(15):1583-1584. doi: 10.1001/jama.2017.1282. No abstract available.

PMID:
28418487
13.

ICU design in 2050: looking into the crystal ball!

Halpern NA, Anderson DC, Kesecioglu J.

Intensive Care Med. 2017 May;43(5):690-692. doi: 10.1007/s00134-017-4728-x. Epub 2017 Mar 17. No abstract available.

PMID:
28315042
14.

High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury.

Sikma MA, Hunault CC, van de Graaf EA, Verhaar MC, Kesecioglu J, de Lange DW, Meulenbelt J.

Eur J Clin Pharmacol. 2017 May;73(5):573-580. doi: 10.1007/s00228-017-2204-8. Epub 2017 Jan 28.

15.

Awake ECMO on the move to lung transplantation: serial monitoring of physical condition.

Hermens JA, Braithwaite SA, Platenkamp M, Wijnandts PR, Van de Graaf EA, van der Kaaij NP, De Jong M, Heijnen G, Janssen J, Kesecioglu J, Donker DW.

Intensive Care Med. 2017 May;43(5):707-708. doi: 10.1007/s00134-016-4667-y. Epub 2017 Jan 23. No abstract available.

PMID:
28116453
16.

In memoriam: Johan Groeneveld.

Girbes A, Kesecioglu J.

Intensive Care Med. 2016 Dec;42(12):1854-1855. doi: 10.1007/s00134-016-4575-1. Epub 2016 Oct 10. No abstract available.

PMID:
27725993
17.

The need for ICU admission in intoxicated patients: a prediction model.

Brandenburg R, Brinkman S, de Keizer NF, Kesecioglu J, Meulenbelt J, de Lange DW.

Clin Toxicol (Phila). 2017 Jan;55(1):4-11. doi: 10.1080/15563650.2016.1222616. Epub 2016 Sep 20.

PMID:
27644313
18.

Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.

de Jong E, van Oers JA, Beishuizen A, Vos P, Vermeijden WJ, Haas LE, Loef BG, Dormans T, van Melsen GC, Kluiters YC, Kemperman H, van den Elsen MJ, Schouten JA, Streefkerk JO, Krabbe HG, Kieft H, Kluge GH, van Dam VC, van Pelt J, Bormans L, Otten MB, Reidinga AC, Endeman H, Twisk JW, van de Garde EMW, de Smet AMGA, Kesecioglu J, Girbes AR, Nijsten MW, de Lange DW.

Lancet Infect Dis. 2016 Jul;16(7):819-827. doi: 10.1016/S1473-3099(16)00053-0. Epub 2016 Mar 2.

PMID:
26947523
19.

How should clinicians respond to requests for potentially inappropriate treatment?

Bosslet GT, Kesecioglu J, White DB.

Intensive Care Med. 2016 Mar;42(3):422-5. doi: 10.1007/s00134-015-4192-4. Epub 2016 Jan 13. No abstract available.

PMID:
26762106
20.

Antibiotic-Induced Within-Host Resistance Development of Gram-Negative Bacteria in Patients Receiving Selective Decontamination or Standard Care.

Noteboom Y, Ong DS, Oostdijk EA, Schultz MJ, de Jonge E, Purmer I, Bergmans D, Fijen JW, Kesecioglu J, Bonten MJ.

Crit Care Med. 2015 Dec;43(12):2582-8. doi: 10.1097/CCM.0000000000001298.

PMID:
26448616
21.

Cytomegalovirus reactivation and mortality in patients with acute respiratory distress syndrome.

Ong DS, Spitoni C, Klein Klouwenberg PM, Verduyn Lunel FM, Frencken JF, Schultz MJ, van der Poll T, Kesecioglu J, Bonten MJ, Cremer OL.

Intensive Care Med. 2016 Mar;42(3):333-41. doi: 10.1007/s00134-015-4071-z. Epub 2015 Sep 28.

22.

What is new in selective decontamination of the digestive tract?

Kesecioglu J, Eggimann P.

Intensive Care Med. 2016 Aug;42(8):1270-5. doi: 10.1007/s00134-015-4009-5. Epub 2015 Aug 18. Review. No abstract available.

23.

Pharmacokinetics and Toxicity of Tacrolimus Early After Heart and Lung Transplantation.

Sikma MA, van Maarseveen EM, van de Graaf EA, Kirkels JH, Verhaar MC, Donker DW, Kesecioglu J, Meulenbelt J.

Am J Transplant. 2015 Sep;15(9):2301-13. doi: 10.1111/ajt.13309. Epub 2015 Jun 4. Review.

24.

An Official ATS/AACN/ACCP/ESICM/SCCM Policy Statement: Responding to Requests for Potentially Inappropriate Treatments in Intensive Care Units.

Bosslet GT, Pope TM, Rubenfeld GD, Lo B, Truog RD, Rushton CH, Curtis JR, Ford DW, Osborne M, Misak C, Au DH, Azoulay E, Brody B, Fahy BG, Hall JB, Kesecioglu J, Kon AA, Lindell KO, White DB; American Thoracic Society ad hoc Committee on Futile and Potentially Inappropriate Treatment; American Thoracic Society; American Association for Critical Care Nurses; American College of Chest Physicians; European Society for Intensive Care Medicine; Society of Critical Care.

Am J Respir Crit Care Med. 2015 Jun 1;191(11):1318-30. doi: 10.1164/rccm.201505-0924ST.

PMID:
25978438
25.

Comparing intensive care units by size or level.

de Lange DW, Wunsch H, Kesecioglu J.

Intensive Care Med. 2015 Feb;41(2):357-9. doi: 10.1007/s00134-015-3678-4. Epub 2015 Jan 24. No abstract available.

PMID:
25617265
26.

The role of systemic antibiotics in acquiring respiratory tract colonization with gram-negative bacteria in intensive care patients: a nested cohort study.

Jongerden IP, Speelberg B, Satizábal CL, Buiting AG, Leverstein-van Hall MA, Kesecioglu J, Bonten MJ.

Crit Care Med. 2015 Apr;43(4):774-80. doi: 10.1097/CCM.0000000000000768.

PMID:
25493969
27.

Use of selective digestive tract decontamination in European intensive cares: the ifs and whys.

Reis Miranda D, Citerio G, Perner A, Dimopoulos G, Torres A, Hoes A, Beale R, De Smet AM, Kesecioglu J.

Minerva Anestesiol. 2015 Jul;81(7):734-42. Epub 2014 Dec 5.

28.

Single-center large-cohort study into quality of life in Dutch intensive care unit subgroups, 1 year after admission, using EuroQoL EQ-6D-3L.

Soliman IW, de Lange DW, Peelen LM, Cremer OL, Slooter AJ, Pasma W, Kesecioglu J, van Dijk D.

J Crit Care. 2015 Feb;30(1):181-6. doi: 10.1016/j.jcrc.2014.09.009. Epub 2014 Sep 22.

PMID:
25305070
29.

Effects of decontamination of the oropharynx and intestinal tract on antibiotic resistance in ICUs: a randomized clinical trial.

Oostdijk EAN, Kesecioglu J, Schultz MJ, Visser CE, de Jonge E, van Essen EHR, Bernards AT, Purmer I, Brimicombe R, Bergmans D, van Tiel F, Bosch FH, Mascini E, van Griethuysen A, Bindels A, Jansz A, van Steveninck FAL, van der Zwet WC, Fijen JW, Thijsen S, de Jong R, Oudbier J, Raben A, van der Vorm E, Koeman M, Rothbarth P, Rijkeboer A, Gruteke P, Hart-Sweet H, Peerbooms P, Winsser LJ, van Elsacker-Niele AW, Demmendaal K, Brandenburg A, de Smet AMGA, Bonten MJM.

JAMA. 2014 Oct 8;312(14):1429-1437. doi: 10.1001/jama.2014.7247.

PMID:
25271544
30.

Seeking worldwide professional consensus on the principles of end-of-life care for the critically ill. The Consensus for Worldwide End-of-Life Practice for Patients in Intensive Care Units (WELPICUS) study.

Sprung CL, Truog RD, Curtis JR, Joynt GM, Baras M, Michalsen A, Briegel J, Kesecioglu J, Efferen L, De Robertis E, Bulpa P, Metnitz P, Patil N, Hawryluck L, Manthous C, Moreno R, Leonard S, Hill NS, Wennberg E, McDermid RC, Mikstacki A, Mularski RA, Hartog CS, Avidan A.

Am J Respir Crit Care Med. 2014 Oct 15;190(8):855-66. doi: 10.1164/rccm.201403-0593CC.

PMID:
25162767
31.

Long-term functional consequences and ongoing cerebral inflammation after subarachnoid hemorrhage in the rat.

Kooijman E, Nijboer CH, van Velthoven CT, Mol W, Dijkhuizen RM, Kesecioglu J, Heijnen CJ.

PLoS One. 2014 Mar 6;9(6):e90584. doi: 10.1371/journal.pone.0090584. eCollection 2014.

32.

Medical research in emergency research in the European Union member states: tensions between theory and practice.

Kompanje EJ, Maas AI, Menon DK, Kesecioglu J.

Intensive Care Med. 2014 Apr;40(4):496-503. doi: 10.1007/s00134-014-3243-6. Epub 2014 Feb 26. Review.

PMID:
24570266
33.

Active von Willebrand factor predicts 28-day mortality in patients with systemic inflammatory response syndrome.

Hyseni A, Kemperman H, de Lange DW, Kesecioglu J, de Groot PG, Roest M.

Blood. 2014 Apr 3;123(14):2153-6. doi: 10.1182/blood-2013-08-508093. Epub 2014 Jan 23.

34.

The rodent endovascular puncture model of subarachnoid hemorrhage: mechanisms of brain damage and therapeutic strategies.

Kooijman E, Nijboer CH, van Velthoven CT, Kavelaars A, Kesecioglu J, Heijnen CJ.

J Neuroinflammation. 2014 Jan 3;11:2. doi: 10.1186/1742-2094-11-2. Review.

35.

Determinants of procedural pain intensity in the intensive care unit. The Europain® study.

Puntillo KA, Max A, Timsit JF, Vignoud L, Chanques G, Robleda G, Roche-Campo F, Mancebo J, Divatia JV, Soares M, Ionescu DC, Grintescu IM, Vasiliu IL, Maggiore SM, Rusinova K, Owczuk R, Egerod I, Papathanassoglou ED, Kyranou M, Joynt GM, Burghi G, Freebairn RC, Ho KM, Kaarlola A, Gerritsen RT, Kesecioglu J, Sulaj MM, Norrenberg M, Benoit DD, Seha MS, Hennein A, Periera FJ, Benbenishty JS, Abroug F, Aquilina A, Monte JR, An Y, Azoulay E.

Am J Respir Crit Care Med. 2014 Jan 1;189(1):39-47. doi: 10.1164/rccm.201306-1174OC.

PMID:
24262016
36.

Increased mortality in systemic inflammatory response syndrome patients with high levels of coagulation factor VIIa.

Hyseni A, Kemperman H, de Lange DW, de Groot PG, Linssen M, Kesecioglu J, Lisman T, Roest M.

J Thromb Haemost. 2013 Dec;11(12):2111-7. doi: 10.1111/jth.12427.

37.

Triage of intensive care patients: identifying agreement and controversy.

Sprung CL, Danis M, Iapichino G, Artigas A, Kesecioglu J, Moreno R, Lippert A, Curtis JR, Meale P, Cohen SL, Levy MM, Truog RD.

Intensive Care Med. 2013 Nov;39(11):1916-24. doi: 10.1007/s00134-013-3033-6. Epub 2013 Aug 8.

38.

Effect of intensive care environment on family and patient satisfaction: a before-after study.

Jongerden IP, Slooter AJ, Peelen LM, Wessels H, Ram CM, Kesecioglu J, Schneider MM, van Dijk D.

Intensive Care Med. 2013 Sep;39(9):1626-34. doi: 10.1007/s00134-013-2966-0. Epub 2013 Jun 6.

PMID:
23740277
39.

Colistin resistance in gram-negative bacteria during prophylactic topical colistin use in intensive care units.

Oostdijk EA, Smits L, de Smet AM, Leverstein-van Hall MA, Kesecioglu J, Bonten MJ.

Intensive Care Med. 2013 Apr;39(4):653-60. doi: 10.1007/s00134-012-2761-3. Epub 2012 Dec 1.

PMID:
23203301
40.

Intensive care unit environment may affect the course of delirium.

Zaal IJ, Spruyt CF, Peelen LM, van Eijk MM, Wientjes R, Schneider MM, Kesecioglu J, Slooter AJ.

Intensive Care Med. 2013 Mar;39(3):481-8. doi: 10.1007/s00134-012-2726-6. Epub 2012 Oct 24.

PMID:
23093246
41.

Structure and function: planning a new ICU to optimize patient care.

Kesecioglu J, Schneider MM, van der Kooi AW, Bion J.

Curr Opin Crit Care. 2012 Dec;18(6):688-92. doi: 10.1097/MCC.0b013e328358d4bd. Review.

PMID:
23010634
42.

Renal artery stenosis: a classic presentation, a rare cause...

Woittiez KJ, van Buren M, Kesecioglu J.

BMJ Case Rep. 2012 Aug 13;2012. pii: bcr2012006499. doi: 10.1136/bcr-2012-006499.

43.

Endoscopic clip-assisted feeding tube placement reduces repeat endoscopy rate: results from a randomized controlled trial.

Hirdes MM, Monkelbaan JF, Haringman JJ, van Oijen MG, Siersema PD, Pullens HJ, Kesecioglu J, Vleggaar FP.

Am J Gastroenterol. 2012 Aug;107(8):1220-7. doi: 10.1038/ajg.2012.169. Epub 2012 Jul 3. Erratum in: Am J Gastroenterol. 2013 Mar;108(3):460. Pullens, Paul H J M [corrected to Pullens, Hendrikus J M].

PMID:
22751469
44.

Decontamination of cephalosporin-resistant Enterobacteriaceae during selective digestive tract decontamination in intensive care units.

Oostdijk EA, de Smet AM, Kesecioglu J, Bonten MJ; Dutch SOD-SDD Trialists Group.

J Antimicrob Chemother. 2012 Sep;67(9):2250-3. Epub 2012 May 29.

PMID:
22643189
45.

Changes in heart rate, mean arterial pressure, and oxygen saturation after open and closed endotracheal suctioning: a prospective observational study.

Jongerden IP, Kesecioglu J, Speelberg B, Buiting AG, Leverstein-van Hall MA, Bonten MJ.

J Crit Care. 2012 Dec;27(6):647-54. doi: 10.1016/j.jcrc.2012.02.016. Epub 2012 Apr 18.

PMID:
22520496
46.

Prolonged use of extracorporeal membrane oxygenation combined with prone positioning in patients with acute respiratory distress syndrome and invasive Aspergillosis.

Otterspoor LC, Smit FH, van Laar TJ, Kesecioglu J, van Dijk D.

Perfusion. 2012 Jul;27(4):335-7. doi: 10.1177/0267659112442098. Epub 2012 Mar 21.

PMID:
22438221
47.

The Eldicus prospective, observational study of triage decision making in European intensive care units. Part II: intensive care benefit for the elderly.

Sprung CL, Artigas A, Kesecioglu J, Pezzi A, Wiis J, Pirracchio R, Baras M, Edbrooke DL, Pesenti A, Bakker J, Hargreaves C, Gurman G, Cohen SL, Lippert A, Payen D, Corbella D, Iapichino G.

Crit Care Med. 2012 Jan;40(1):132-8. doi: 10.1097/CCM.0b013e318232d6b0.

PMID:
22001580
48.

The Eldicus prospective, observational study of triage decision making in European intensive care units: part I--European Intensive Care Admission Triage Scores.

Sprung CL, Baras M, Iapichino G, Kesecioglu J, Lippert A, Hargreaves C, Pezzi A, Pirracchio R, Edbrooke DL, Pesenti A, Bakker J, Gurman G, Cohen SL, Wiis J, Payen D, Artigas A.

Crit Care Med. 2012 Jan;40(1):125-31. doi: 10.1097/CCM.0b013e31822e5692.

PMID:
21926598
49.

Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care units.

Ong DS, Jongerden IP, Buiting AG, Leverstein-van Hall MA, Speelberg B, Kesecioglu J, Bonten MJ.

Crit Care Med. 2011 Nov;39(11):2458-63. doi: 10.1097/CCM.0b013e318225756d.

PMID:
21705892
50.

Effect of open and closed endotracheal suctioning on cross-transmission with Gram-negative bacteria: a prospective crossover study.

Jongerden IP, Buiting AG, Leverstein-van Hall MA, Speelberg B, Zeidler S, Kesecioglu J, Bonten MJ.

Crit Care Med. 2011 Jun;39(6):1313-21. doi: 10.1097/CCM.0b013e3182120815.

PMID:
21358397

Supplemental Content

Loading ...
Support Center